Total revenue was $573.7 million in the 3rd quarter of 2013 and $537.1 million in the 3rd quarter of 2012. Large Case Pensions business outcomes Large Case Pensions, which manages a variety of discontinued and various other retirement and savings products, primarily for experienced pension plans, reported: Operating revenue of $6.2 million for the third quarter of 2013 compared with $3.7 million for the 3rd quarter of 2012. Net gain of $2.4 million for the third quarter of 2013 compared with $.8 million for the third quarter of 2012.7 million for the 3rd quarter of 2013 compared with $124.3 million for the third quarter of 2012.These immune responses act like the ones that occur in individuals with a self-resolving severe HBV infection. ABX203 is formulated as a nasal spray option and as a remedy for sub-cutaneous injection. ABIVAX owns distribution privileges for ABX203 for more than 80 territories in Asia, Africa and Europe. They were licensed in 2013 from the guts for Genetic Engineering and Biotechnology following a completion of successful phase I, I/II and III clinical trials work by CIGB in Cuba and Bangladesh. This unique sustained effect, in addition to a shorter duration of administration, means that ABX203 may offer important therapeutic advantages over standard remedies for CHB.